Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and ...

A real-world analysis of nearly 7000 patients shows GLP-1s are associated with sharply lower death rates at 5 years in ...

GLP-1 receptor agonists like Ozempic and Wegovy may increase survival among patients with colon cancer. | Drug Discovery And ...

A new study, with help from artificial intelligence, focuses on reprogramming cancer stem cells and triggering some to ‘self-destruct’ ...

Study researchers found no link between more liver fat and poor outcomes in patients with stage I-III rectal cancer.

A man in his seventies developed fulminant capecitabine toxicity despite normal DPYD screening, revealing a rare variant that ...

The American Gastroenterological Association (AGA) has released a comprehensively updated clinical guideline on the ...

The FDA is asking drug manufacturers to remove black box warnings on hormone replacement therapy for menopause, which could ...

It started with skincare and biotin gummies, then escalated into Pilates and AI-curated supplement regimens before I found ...

A new groundbreaking light therapy could kill cancer cells in just 30 minutes, scientists have discovered. In the new method, researchers from the University of Texas at Austin fired infrared light, a ...

A UC San Diego study reveals GLP-1 receptor agonists, like Ozempic, may significantly reduce colon cancer death rates.